Bloch MJ. Worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens. 2016;10:753–4.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.
Akintunde AA, Akintunde TS. Antihypertensive medications adherence among Nigerian hypertensive subjects in a specialist clinic compared to a general outpatient clinic. Ann Med Health Sci Res. 2015;5:173–8.
Adeloye D. An estimate of the incidence and prevalence of stroke in Africa: a systematic review and meta-analysis. PLoS One. 2014;9:e100724.
Lemogoum D, Van de Borne P, Lele CEB, Damasceno A, Ngatchou W, Amta P, et al. Prevalence, awareness, treatment, and control of hypertension among rural and urban dwellers of the far north region of Cameroon. J Hypertens. 2018;36:159–68.
Tianyi FL, Agbor VN, Njamnshi AK. Prevalence, awareness, treatment, and control of hypertension in Cameroonians aged 50 years and older: A community-based study. Health Sci Rep. 2018;1:e44.
Jingi A, Dzudie A, Noubiap JJ, Menanga AP, Aminde L, Fesuh B, et al. [PS 03–24] Hypertension prevalence, awareness and control in Cameroon: a systematic review with projections for 2025 and 2035. J Hypertens. 2016;34:e132.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.
van Veen WA. Treatment adherence in hypertension: problems and research. J R Coll Gen Pract Occas Pap. 1980;(12):22–5.
Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62:218–25.
van der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31:687–94.
Agbor VN, Essouma M, Ntusi NAB, Nyaga UF, Bigna JJ, Noubiap JJ. Heart failure in sub-Saharan Africa: a contemporaneous systematic review and meta-analysis. Int J Cardiol. 2018;257:207–15.
Nyaga U, Bigna JJR, Agbor VN, Essouma M, NAB N, Noubiap JJ. Data on the epidemiology of heart failure in Sub-Saharan Africa. Int J Cardiol. 2018; https://doi.org/10.1016/j.dib.2018.01.100.
Tadesse M, Eyob A, Akshay S, Asim A. Nonadherence to antihypertensive drugs. A systematic review and meta-analysis. Medicine. 2017;96:e5647.
Hussanin SM, Boonshuyar C, Ekram A. Non-adherence to antihypertensive treatment in essential hypertensive patients in Rajshahi, Bangladesh. Anwer Khan Modern Med Coll J. 2011;2:9–14.
Nguyen T-P-L, Schuiling-Veninga CCM, Nguyen TBY, Vu T-H, Wright EP, Postma MJ. Adherence to hypertension medication: quantitative and qualitative investigations in a rural northern Vietnamese community. PLoS One. 2017;12:e0171203.
Boima V, Ademola AD, Odusola AO, Agyekum F, Nwafor CE, Cole H, et al. Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria. Int J Hypertens [Internet]. 2015; Available from: https://www.hindawi.com/journals/ijhy/2015/205716/. [cited 29 May 2018]
Akoko BM, Fon PN, Ngu RC, Ngu KB. Knowledge of hypertension and compliance with therapy among hypertensive patients in the Bamenda Health District of Cameroon: a cross-sectional study. Cardiol Ther. 2017;6:53–67.
Mbouemboue O, Tamanji M, Gambara R, Lokgue Y, Ngoufack J. Determinants of therapeutic nonadherence to antihypertensive treatment: a hospital-based study on outpatients in northern Cameroon. 2015.
Busari O, Olanrewaju T, Desalu O, Opadijo O, Kayode J, Agboola S, et al. Impact of PatientsAND#8217; Knowledge, Attitude and Practices on Hypertension on Compliance with Antihypertensive Drugs in a Resource-poor Setting. 2010.
Agbornkwai N. An assessment of the knowledge, attitutes and practice of preventive measures against HIV/AIDS among students of the University of Buea. Buea: University of Buea; 2012.
Ekram AS, Hussain SM, Boonshuyar C. Preliminary report on non-adherence to antihypertensive treatment in essential hypertensive patients: a community based survey. 2009.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.
Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk factors for nonadherence to antihypertensive TreatmentNovelty and significance. Hypertension. 2017;69:1113–20.
Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician. 2013;59:e93–100.
Jingi AM, Noubiap JJN, Onana AE, Nansseu JRN, Wang B, Kingue S, et al. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, Availability and Affordability in the West Region of Cameroon. PLOS ONE. 2014;9:e111812.
Mekonnen HS, Gebrie MH, Eyasu KH, Gelagay AA. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacol Toxicol. 2017;18:27.
Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag. 2005;1:93–106.
Jambedu HA. Adherence to anti-hypertensive medication regimens among patients attending the G.P.H.A. Hospital in Takoradi - Ghana. [Internet]. Thesis. 2006; Available from: http://ir.knust.edu.gh/xmlui/handle/123456789/677. [cited 31 May 2018]
Wariva E, January J, Maradzika J. Medication adherence among elderly patients with high blood pressure in Gweru, Zimbabwe. J Public Health Africa. 2014;5(1):304.
Ohene KB, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci. 2004;7:350–2.
Amira CO, Okubadejo NU. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians. Niger Postgrad Med J. 2007;14:325–9.
Al-Ramahi R. Adherence to medications and associated factors: a cross-sectional study among Palestinian hypertensive patients. J Epidemiol Glob Health. 2015;5:125–32.
Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Heart failure in Africa, Asia, the Middle East and South America: the INTER-CHF study. Int J Cardiol. 2016;204:133–41.
Okoro R, Ngong K. Assessment of patient’s antihypertensive medication adherence level in non-comorbid hypertension in a tertiary hospital in Nigeria. 2012.
Chelkeba L, Dessie S. Antihypertension medication adherence and associated factors at Dessie hospital, north East Ethiopia, Ethiopia. International journal of research in medical. Sciences. 2017;1:191–7.
Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;16:577–83.
Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J. 1999;160:41–6.
Khayyat SM, Khayyat SMS, Alhazmi RSH, Mohamed MMA, Hadi MA. Predictors of medication adherence and blood pressure control among Saudi hypertensive patients attending primary care clinics: a cross-sectional study. PLoS One. 2017;12:e0171255.
Benson S, Vance-Bryan K, Raddatz J. Time to patient discontinuation of antihypertensive drugs in different classes. Am J Health Syst Pharm. 2000;57:51–4.
Wogen J, Krelick CA, Livornese RC, Yokoyama K, Frech F. Patient adherence with amlodipine, Lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm. 2003;9:424–9.
Al Ghobain M, Alhashemi H, Aljama A, Bin Salih S, Assiri Z, Alsomali A, et al. Nonadherence to antihypertensive medications and associated factors in general medicine clinics. Patient Prefer Adherence. 2016;10:1415–9.
Tong X, Chu EK, Fang J, Wall HK, Ayala C. Nonadherence to antihypertensive medication among hypertensive adults in the United States─HealthStyles, 2010. J Clin Hypertens. 2016;18:892–900.
Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens. 2002;16:439–44.
Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis Medicine (Baltimore). 2017;96(4):e5641.
Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Sundell KA, Petzold M, et al. Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications? PLoS One. 2015;10:e0137451.
Department of biostatistics, Vanderbilt University. Problems Caused by Categorizing Continuous Variables [Internet]. Available from: http://biostat.mc.vanderbilt.edu/wiki/Main/CatContinuous. [cited 4 June 2018]
Agbor VN, Takah NF, Aminde LN. Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: protocol for a systematic review and meta-analysis. BMJ Open. 2018;8:e020715.
Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239–45.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.
Dzudie A, Rayner B, Ojji D, Schutte AE, Twagirumukiza M, Damasceno A, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc J Afr. 2017;28:262–72.
Tan X, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). Inov Pharm. 2014;5:165.